Sohanya Roshan Cheng, EVP & Chief Commercial Officer at Karyopharm Therapeutics Inc. (KPTI), sold 325 shares at $6.43 ($2K) on 2025-09-15, disclosed to the SEC on 2025-09-16.
Seasonal sale ($2k) by EVP & Chief Commercial Officer — this insider has traded KPTI in September in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2025-03-06 | $22K | — | Filing → |
| KPTI | SELL | 2024-09-05 | $4K | — | Filing → |
| KPTI | SELL | 2024-03-04 | $32K | — | Filing → |